Mon, October 16, 2023

Olivia Brayer Maintained (ALNY) at Hold with Decreased Target to $170 on, Oct 16th, 2023

Olivia Brayer of Cantor Fitzgerald, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $190 to $170 on, Oct 16th, 2023.

Olivia has made no other calls on ALNY in the last 4 months.



There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 2 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, October 11th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $175 on, Tuesday, October 10th, 2023


These are the ratings of the 8 analyists that currently disagree with Olivia


  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $235 on, Wednesday, October 11th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $395 on, Wednesday, October 11th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
  • Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023